Temasek acquired a 30% stake in Aerogen.

Temasek, a global investment company headquartered in Singapore, acquired a 30% stake in Aerogen, the world leader in acute care aerosol drug delivery. Financial terms were not disclosed. John Power, founder and CEO of Aerogen, remarked, “We are excited to realize the growth opportunities this collaboration will bring. Temasek, our partner of choice, has deep global and sector expertise, which will accelerate our market penetration.”